COST EFFECTIVENESS OF CYCLOPHOSPHAMIDE IN THE ADJUVANT TREATMENT OF BREAST CANCER IN EUROPE: A MULTI-COUNTRY STUDY

被引：0
|
作者：
Walter, E. [1 ]
Mercsanits, D. [1 ]
机构：
[1] Inst Pharmaecon Res, Vienna, Austria
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.2114
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A422 / A422
页数：1
相关论文
共 50 条
  • [21] Cost effectiveness of trastuzumab in adjuvant treatment of early breast cancer: A model based analysis
    Dedes, Konstantin J.
    Szucs, Thomas D.
    Imesch, Patrick
    Fehr, Mathias K.
    Fink, Daniel
    ANNALS OF ONCOLOGY, 2006, 17 : 95 - 95
  • [22] Tinnitus prevalence in Europe: a multi-country cross-sectional population study
    Biswas, R.
    Lugo, A.
    Akeroyd, M. A.
    Schlee, W.
    Gallus, S.
    Hall, D. A.
    LANCET REGIONAL HEALTH-EUROPE, 2022, 12
  • [23] The multi-country evaluation of Integrated Management of Childhood Illness (IMCI) effectiveness, cost and impact - Foreword
    Mason, E
    HEALTH POLICY AND PLANNING, 2005, 20 : I1 - I1
  • [24] Cost-Effectiveness Analysis of Adjuvant Therapy for Operable Breast Cancer from a Chinese PerspectiveDoxorubicin plus Cyclophosphamide versus Docetaxel plus Cyclophosphamide
    Peng Liubao
    Wan Xiaomin
    Tan Chongqing
    Jon Karnon
    Chen Gannong
    Li Jianhe
    Cui Wei
    Luo Xia
    Cao Junhua
    PharmacoEconomics, 2009, 27 : 873 - 886
  • [25] Erratum to: Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide + methotrexate + fluorouracil in patients with node-positive breast cancer
    A. Messori
    P. Becagli
    S. Trippoli
    E. Tendi
    European Journal of Clinical Pharmacology, 1997, 51 : 427 - 427
  • [26] Adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF) in breast cancer - Is it cost-effective ?
    Norum, J
    ACTA ONCOLOGICA, 2000, 39 (01) : 33 - 39
  • [27] Adjuvant fluorouracil, epirubicin and cyclophosphamide in early breast cancer: Is it cost-effective?
    Norum, J
    Holtmon, M
    ACTA ONCOLOGICA, 2005, 44 (07) : 735 - 741
  • [28] Improvement of early detection of breast cancer through collaborative multi-country efforts: Observational clinical study
    Aribal, Erkin
    Mora, Patricia
    Chaturvedi, Arvind K.
    Hertl, Kristijana
    Davidovic, Jasna
    Salama, Dina H.
    Gershan, Vesna
    Kadivec, Maksimilian
    Odio, Clara
    Popli, Manju
    Kisembo, Harriet
    Sabih, Zahida
    Vujnovic, Sasa
    Kayhan, Arda
    Delis, Harry
    Paez, Diana
    Giammarile, Francesco
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 115 : 31 - 38
  • [29] The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer
    Younis, T.
    Rayson, D.
    Skedgel, C.
    CURRENT ONCOLOGY, 2011, 18 (06) : E288 - E296
  • [30] COST-EFFECTIVENESS OF ADJUVANT THERAPY WITH TRASTUZUMAB IN THE TREATMENT OF EARLY BREAST CANCER (EBC) IN ROMANIA
    Grecea, D.
    Baculea, S.
    Radu, P. C.
    Pana, B.
    Szkultecka-Debek, M.
    VALUE IN HEALTH, 2010, 13 (03) : A42 - A42
12345